MedPath

Chemical determination of AGE levels and serum concentrations of free light chains in hemodialysis patients compared to healthy subjects

Conditions
N18.5
Chronic kidney disease, stage 5
Registration Number
DRKS00017244
Lead Sponsor
niversitätsklinikum Halle (Saale), Klinik für Innere Medizin II
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
16
Inclusion Criteria

1. No significant chronic diseases (e.g., diabetes mellitus, poorly controlled high blood pressure)
2. Participants in the PERCI II trial (for dialysis patients)

Exclusion Criteria

1. Acute infection
2. Acute illness that prohibits participation in the study at the investigator's discretion
3. Women of childbearing potential who are not more than 2 years in menopause
4. Consent not given

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
There are no endpoints in this study. However, the concentrations of the AGE (Advanced Glycation Endproducts) and the free light chains kappa and lambda are determined. The analysis is done as a descriptive statistics and correlation.
Secondary Outcome Measures
NameTimeMethod
see primary endpoint
© Copyright 2025. All Rights Reserved by MedPath